ChainPeptides Oy

ChainPeptides Oy: Develops antimicrobial peptide solutions for chronic wounds and drug-resistant bacterial infections. BioTech · Pre-Seed · Oulu, Finland.…

Develops antimicrobial peptide solutions for chronic wounds and drug-resistant bacterial infections.

Preliminary profile · public data only

Startup24 listed ChainPeptides Oy from public information on the company's own website; its founders have not claimed or verified the profile yet. The rating below is preliminary, based on public data only, and is an opinion — not investment advice. Founders can claim the profile, and anyone can report an error or request removal, on this page.

At a glance

• Category: BioTech (Antimicrobial peptides for chronic wound care)
• Stage: Pre-Seed
• Location: Oulu, Finland

Startup24 rating: 58/100

ChainPeptides Oy is a Finnish pre-seed biotech pursuing a patent-backed antimicrobial peptide platform for chronic wounds and drug-resistant infections.

About the rating

Every startup on Startup24 is scored on the same six criteria — team, market, product, advantages, risk and reputation — with the reasoning written out. Founders list for free; investors subscribe to see the full analysis.

• How the score is calculated
• Browse the catalogue

Startup24 (startup-24.com) rates startups on real, verified data: founders list for free, investors subscribe to find them first. Operated by DOTOVO OÜ, Tallinn, Estonia.